Search results for: 'Well owners and testing'
- Did you mean
- well owners ad testing
- Related search terms
- AND (SELECT (CASE WHEN (3989=1399) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,3989) END) FROM DUAL) IS NULL
- AND (SELECT (CASE WHEN (4327=4327) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,4327) END) FROM DUAL) IS NULL
- AND (SELECT (CASE WHEN (1509=3753) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,1509) END) FROM DUAL) IS NULL-- wUvH
- AND (SELECT 1827 FROM (SELECT(SLEEP(20)))zydf)
- wellness and beauty united arab emirates
-
30 Jun 2021  |  North America  |  Market Research
US & EU Direct-to-consumer Genetic Testing Market, Key Trends & Growth Opportunities
Telegenetic Counseling to Revolutionize Access to Patient Care
In 2003, the first human genome sequence was produced, with a production cost between $500 million and $1 billion. However, since 2008, when next-generation sequencing (NGS) approaches entered the research setting, there has been a significant decline in sequencing costs. These approaches allow either the whole genome (via whole-genome sequencing [...
$2,450.00
Special Price $1,837.50 save 25 %
-
31 Jan 2020  |  North America  |  Market Research
Predictions for the Global Life Sciences Industry, 2020
COVID-19 Pandemic will Drive New Digital-tech Adoption in Drug Discovery and Testing Services, and Federal Funding will Encourage Stronger Product Pipelines
The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...
$1,500.00
Special Price $1,125.00 save 25 %
-
03 Feb 2023  |  North America  |  Market Research
Global Pharmaceutical Continuous Manufacturing Market, Growth Opportunities
Regulatory Acceptance Propelling Continuous Manufacturing Investments through Partnerships and In-house Expansions
Continuous manufacturing (CM) is a method for manufacturing end-to-end pharmaceutical products on a single, uninterrupted production line. While batch manufacturing requires transporting, testing, and refeeding materials from one process to the next, continuous processes execute all testing, feeding, and processing inline at a single manufacturing ...
$4,950.00
Special Price $3,712.50 save 25 %
-
20 Mar 2019  |  North America  |  Market Research
2019 Predictions of the Global Life Sciences Industry
As Novel Technologies Find Traction, Industry Focus Will Shift Towards Successful Monetization to Deliver Value-based Care
he global life science industry is in a state of flux. While the recent years have seen the advent of multiple novel technologies, such as in-vitro diagnostics (IVD), CRISPR-Cas9, virtual clinical trials, and liquid biopsy, the industry stands at a crossroad with challenges in scaling-up and commercializing such technologies. In addition, companies...
$1,500.00
Special Price $1,125.00 save 25 %
-
05 Feb 2021  |  North America  |  Market Research
Shifting Spotlight from Product- to Value-based Outcomes Intensifies Growth in the US Real-world Evidence IT Solutions Market
Early-stage R&D and Commercial Applications Fuel the Growth Pipeline
The US healthcare industrys transition to a patient-centric model is moving rapidly with focus on outcomes and value; however, drug prices have increased and pharmaceutical research and development (R&D) productivity is at its lowest. The healthcare industry and IT solutions providers are finding real-world evidence (RWE) as a potential solution to...
$4,950.00
Special Price $3,712.50 save 25 %
-
13 Sep 2021  |  North America  |  Market Research
Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities
Emerging Pharmaceuticals and Highly Potent Complex Molecules Creating Future Growth Potential
This study presents Frost & Sullivan’s overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of p...
$4,950.00
Special Price $3,712.50 save 25 %
-
27 Aug 2019  |  North America  |  Market Research
Growth Opportunities in the Neurodegenerative Disorder Therapeutics Market, Forecast to 2024
Digital Solutions will Spark Integrated Development Approaches and Successful Adjunctive Therapies for Disease Modification
As one lives longer, one needs to increasingly battle age-related disorders. Neurodegenerative disorders are the most worrisome, because they impact millions of people around the world and lack any curative therapy. While companies continue their search, they are also battling declining revenues from marketed products used to manage symptoms. Heavy...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Jun 2021  |  North America  |  Market Research
Global Biologics Contract Development and Manufacturing Organizations Growth Opportunities
Asset Co-Development with Clinical-stage Biopharmaceutical Companies and Disruptive Technologies Present Future Growth Potential
This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global biologics contract development and manufacturing organizations (bio-CDMO) market. It also highlights key growth opportunities for bio-CDMO market participants based on the main evolution in their business models and strategic approaches, as well as...
$4,950.00
Special Price $3,712.50 save 25 %
-
19 Dec 2022  |  North America  |  Market Outlook
Top 10 for 2023: Growth Opportunities for the Life Sciences Industry
An increasing focus on biologics, genomics, and multi-omics; the adoption of digital technologies; and a shift to patient-centric models are transforming the life sciences industry. At the same time, the emergence of value-based models, R&D activities to treat complex diseases, and healthcare consumerism provide an impetus to precision medicine. Wi...
$2,450.00
Special Price $1,837.50 save 25 %
-
08 Mar 2022  |  North America  |  Market Outlook
Global Pharmaceuticals Outlook, 2022
The Digitalization of the Pharmaceuticals Value Chain is Opening up New Growth Opportunities for Stakeholders
Frost & Sullivan offers an outlook for the global pharmaceuticals market for 2022-2026, including emerging trends and growth opportunities. Prioritizing booster doses over initial dose coverage is negatively impacting the global mitigation of the COVID-19 pandemic, which is resulting in severe implications on health and social and economic well-bei...
$4,950.00
Special Price $3,712.50 save 25 %